Israel Englander Recursion Pharmaceuticals, Inc. Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 28,310 shares of RXRX stock, worth $179,768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,310
Previous 31,700
10.69%
Holding current value
$179,768
Previous $208,000
8.17%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RXRX
# of Institutions
341Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$216 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$205 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$158 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$110 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$93.1 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.15B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...